Literature DB >> 22215627

Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study.

Casper P Hagen1, Lise Aksglaede, Kaspar Sørensen, Annette Mouritsen, Anna-Maria Andersson, Jørgen Holm Petersen, Katharina M Main, Anders Juul.   

Abstract

BACKGROUND: In adult women, the circulating level of anti-Müllerian hormone (AMH) is a novel marker of ovarian function, as it reflects the number of remaining ovarian follicles. Therefore, AMH has gained widespread attention in fertility clinics, and a low AMH is believed to predict impaired fertility and imminent menopause. However, the natural course of circulating AMH levels during female childhood and adolescence is not known.
METHODS: Serum levels of AMH and FSH were measured in girls participating in The COPENHAGEN Puberty Study. Longitudinal part: 85 healthy girls and adolescents were examined, and blood samples were drawn every 6 months for an average of 3 years: median (range) number of samples per girl was 6 (2-10), age at baseline was 9.2 (5.9-12.9) years. Cross-sectional part: 224 prepubertal girls (age 8.3, 5.6-11.7 years) were examined and each girl had one blood sample drawn.
RESULTS: The individual mean AMH levels in girls followed longitudinally ranged from 5 to 54 pmol/l (median 18 pmol/l). The mean intra-individual coefficient of variation of AMH was 22% (range 0-54%). Overall, each girl maintained her AMH level throughout childhood and adolescence although minor, but significant, changes occurred during pubertal transition. In prepubertal girls, AMH was negatively correlated with FSH (r = -0.31, P < 0.001). Twelve per cent (10/85) had mean AMH below a cut-off value of 8 pmol/l, indicating that the interpretation of low AMH as a marker of approaching menopause may not apply to pre- and peri-pubertal girls.
CONCLUSIONS: Circulating AMH exhibits only minor fluctuations during childhood and adolescence, and a random AMH measurement seems representative for a given girl. The negative AMH-FSH correlation in prepubertal girls supports the notion that AMH is a quantitative marker of ovarian follicles even in young girls.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215627     DOI: 10.1093/humrep/der435

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  29 in total

1.  Genome-wide association study of anti-Müllerian hormone levels in pre-menopausal women of late reproductive age and relationship with genetic determinants of reproductive lifespan.

Authors:  Katherine S Ruth; Ana Luiza G Soares; Maria-Carolina Borges; A Heather Eliassen; Susan E Hankinson; Michael E Jones; Peter Kraft; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Jack A Taylor; Anne Zeleniuch-Jacquotte; Deborah A Lawlor; Anthony J Swerdlow; Anna Murray
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

Review 2.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

3.  AMH is Higher Across the Menstrual Cycle in Early Postmenarchal Girls than in Ovulatory Women.

Authors:  Madison T Ortega; Lauren Carlson; John A McGrath; Tairmae Kangarloo; Judith Mary Adams; Patrick M Sluss; Geralyn Lambert-Messerlian; Natalie D Shaw
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

4.  Reduced serum levels of anti-Müllerian hormone in females with inherited bone marrow failure syndromes.

Authors:  Martha M Sklavos; Pamela Stratton; Neelam Giri; Blanche P Alter; Sharon A Savage; Ligia A Pinto
Journal:  J Clin Endocrinol Metab       Date:  2014-11-18       Impact factor: 5.958

5.  Anti-Muellerian hormone (AMH) as only possible marker in the assessment of ovarian function and reserve after hematopoietic stem cell transplantation (HSCT) in prepubertal girls, young females with composed hypogonadism and females receiving hormonal replacement therapy.

Authors:  A Wędrychowicz; J Wojtyś; J Starzyk
Journal:  Bone Marrow Transplant       Date:  2016-11-14       Impact factor: 5.483

6.  MKRN3 levels in girls with central precocious puberty and correlation with sexual hormone levels: a pilot study.

Authors:  Anna Grandone; Grazia Cirillo; Marcella Sasso; Carlo Capristo; Gianluca Tornese; Pierluigi Marzuillo; Caterina Luongo; Giuseppina Rosaria Umano; Adalgisa Festa; Ruggero Coppola; Emanuele Miraglia Del Giudice; Laura Perrone
Journal:  Endocrine       Date:  2017-03-15       Impact factor: 3.633

7.  A pilot study for exploring blood spot anti-mullerian hormone for population-based adolescent reproductive health research.

Authors:  Kelli S Hall; Shelby T Rentmeester; Yuan Zhao; Allison N Hankus; Yidan Pei; Halley Em Riley; Candace McCloud; Bradley D Pearce
Journal:  Front Womens Health       Date:  2020-02-03

8.  Anti-Müllerian hormone deficiency in females with Fanconi anemia.

Authors:  Martha M Sklavos; Neelam Giri; Pamela Stratton; Blanche P Alter; Ligia A Pinto
Journal:  J Clin Endocrinol Metab       Date:  2014-01-17       Impact factor: 5.958

Review 9.  The ageing ovary and uterus: new biological insights.

Authors:  S M Nelson; E E Telfer; R A Anderson
Journal:  Hum Reprod Update       Date:  2012-10-26       Impact factor: 15.610

10.  Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females.

Authors:  Emma L Anderson; Abigail Fraser; William McNally; Naveed Sattar; Hany Lashen; Richard Fleming; Scott M Nelson; Debbie A Lawlor
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.